Akero Therapeutics (AKRO) Q3 2025 Earnings

Aug 8Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.16
-1.06
-0.96
-0.86

Details

Expected EPS
-0.917119
Actual EPS
-0.86
Surprise EPS
0.06
Surprise Percent
+6.23%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-0.86⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts